CAR T

Joshua D Bernstock1,2,3, Jakob V E Gerstl1, Pablo A Valdés4

  • 1Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

PubMed
概括

化学抗原受体 (CAR) T细胞疗法对复发性质母细胞瘤 (GBM) 显示出前景. 两项第一阶段试验的临时结果表明,这种创新的治疗方法取得了重大进展.